Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Embolism, Atrial Fibrillation and Venous Thrombosis”

96 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 96 results

Testing effectiveness (Phase 2)Study completedNCT00814177
What this trial is testing

Prothrombin Times Outside the Therapeutic Range in Otherwise Stable Patients

Who this might be right for
Atrial FibrillationVenous ThromboembolismIschemic Stroke+1 more
Hamilton Health Sciences Corporation 160
Not applicableUnknownNCT00970892
What this trial is testing

VKORC1 and CYP2C9 Gene Polymorphisms and Warfarin Management

Who this might be right for
Atrial FibrillationCardiac ThrombusDeep Vein Thrombosis+4 more
Ankara University 500
Not applicableStudy completedNCT02864537
What this trial is testing

Self-management of Anticoagulation Treatment

Who this might be right for
Atrial FibrillationVenous ThromboembolismArtificial Heart Valve
University of Bergen 130
Not applicableStudy completedNCT01809015
What this trial is testing

Evaluation of Oral Anticoagulation With Vitamin K Antagonists - The thrombEVAL Study Programme

Who this might be right for
Anticoagulant Antagonists, Vitamin K and Other Coagulants Causing Adverse Effects in Therapeutic UseAtrial FibrillationVenous Thromboembolism
Johannes Gutenberg University Mainz 2,318
Not applicableStudy completedNCT01871194
What this trial is testing

An Observational Post-Authorization Safety Specialist Cohort Event Monitoring Study (SCEM) to Monitor the Safety and Utilization of Rivaroxaban (Xarelto®).

Who this might be right for
Atrial FibrillationDeep Vein ThrombosisPulmonary Embolism
Professor Saad Shakir 3,400
Early research (Phase 1)Study completedNCT02537457
What this trial is testing

Bioequivalence Study of Rivaroxaban

Who this might be right for
Embolism, Atrial Fibrillation and Venous Thrombosis
Bayer 40
Not applicableUnknownNCT04766216
What this trial is testing

Warfarin Patient Self-management Implementation in the US Healthcare System

Who this might be right for
Atrial FibrillationVenous ThromboembolismHeart Valve Diseases
University of Utah 150
Large-scale testing (Phase 3)Study completedNCT02065388
What this trial is testing

Pharmacogenetic Dosing of Warfarin

Who this might be right for
StrokeVenous ThrombosisAtrial Fibrillation+1 more
Academia Sinica, Taiwan 300
Post-approval studies (Phase 4)Study completedNCT02376803
What this trial is testing

The Effect of Medication Timing on Anticoagulation Stability in Users of Warfarin: The "INRange" RCT

Who this might be right for
Atrial FibrillationThrombus Due to Heart Valve ProsthesisDeep Venous Thrombosis+2 more
University of Alberta 217
Not applicableStudy completedNCT03911661
What this trial is testing

Fearon Algorithm in Warfarin Patient Self-Management

Who this might be right for
Atrial FibrillationVenous ThrombosesHeart Valve Diseases
University of Utah 30
Post-approval studies (Phase 4)Study completedNCT00511173
What this trial is testing

Comparison of Warfarin Dosing Using Decision Model Versus Pharmacogenetic Algorithm

Who this might be right for
Atrial FibrillationPulmonary EmbolismDeep Vein Thrombosis
Creighton University 102
Not applicableUnknownNCT00484640
What this trial is testing

Modeling Genotype and Other Factors to Enhance the Safety of Coumadin Prescribing

Who this might be right for
Atrial FibrillationDeep Venous ThrombosisHeart Valve Replacement+1 more
Agency for Healthcare Research and Quality (AHRQ) 260
Large-scale testing (Phase 3)Ended earlyNCT02094157
What this trial is testing

Tapered Warfarin or Interrupted Warfarin With Heparin Bridging for Pacemaker or Defibrillator Implantation

Who this might be right for
Cardiac ArrhythmiasHemorrhageThromboembolism
McMaster University 173
Not applicableLooking for participantsNCT07372716
What this trial is testing

Safety of Perioperative Anticoagulation Management in People With Active Cancer Undergoing Cancer-Related Surgery or Procedures (ACE-HIGH Study)

Who this might be right for
ThrombosisCancerThrombosis, Deep Vein+3 more
Ottawa Hospital Research Institute 700
Large-scale testing (Phase 3)UnknownNCT01817439
What this trial is testing

Safety and Efficacy of Oral Versus Intravenous Amiodarone in the Treatment of AF

Who this might be right for
Atrial Fibrillation
Western Galilee Hospital-Nahariya 104
Not applicableStudy completedNCT04068727
What this trial is testing

LEAVE Safe With DOACs

Who this might be right for
Cardiovascular DiseasesVenous ThromboembolismAtrial Fibrillation+2 more
University of Massachusetts, Worcester 561
Not applicableStudy completedNCT04195113
What this trial is testing

Perioperative Anticoagulant Use for Surgery Evaluation Emergency Registry

Who this might be right for
Atrial FibrillationVenous ThromboembolismArterial Vascular Disease
McMaster University 242
Not applicableStudy completedNCT03015025
What this trial is testing

Pharmacogenetic Dosage Algorithm for Acenocoumarol

Who this might be right for
Atrial FibrillationVenous ThrombosesCardiac Valve Disease
Instituto de Investigación Hospital Universitario La Paz 340
Not applicableStudy completedNCT00334464
What this trial is testing

A Pharmacogenetic Study of Warfarin Dosing, "The COUMA-GEN Study"

Who this might be right for
Atrial FibrillationDeep Vein ThrombosisPulmonary Embolism
Intermountain Health Care, Inc. 200
Not applicableEnrolling By InvitationNCT07654634
What this trial is testing

Precision Antithrombotic Therapy

Who this might be right for
Non-valvular Atrial Fibrillation (NVAF)Venous Thromboembolism (VTE)MI(Myocardial Infarction)+1 more
The Third Xiangya Hospital of Central South University 5,000
Next Page